Hepatitis B virus reactivation during therapy with etanercept in an HBsAg‐negative and anti‐HBs‐positive patient
2008; Wiley; Volume: 28; Issue: 5 Linguagem: Inglês
10.1111/j.1478-3231.2007.01665.x
ISSN1478-3231
AutoresP Martínez Montiel, José Antonio Nieto Solís, Juan Antonio Chirinos, Begoń A Casis, Fernando Sánchez, Sarbelio Rodríguez,
Tópico(s)Liver Disease Diagnosis and Treatment
ResumoLiver InternationalVolume 28, Issue 5 p. 718-720 Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient Pilar Martinez Montiel, Pilar Martinez Montiel Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this authorJose Antonio Solis, Jose Antonio Solis Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this authorJuan Antonio Chirinos, Juan Antonio Chirinos Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this authorBegoń A Casis, Begoń A Casis Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this authorFernando Sánchez, Fernando Sánchez Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this authorSarbelio Rodríguez, Sarbelio Rodríguez Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this author Pilar Martinez Montiel, Pilar Martinez Montiel Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this authorJose Antonio Solis, Jose Antonio Solis Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this authorJuan Antonio Chirinos, Juan Antonio Chirinos Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this authorBegoń A Casis, Begoń A Casis Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this authorFernando Sánchez, Fernando Sánchez Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this authorSarbelio Rodríguez, Sarbelio Rodríguez Department of Digestive Medicine, 12 de Octobre University Hospital, Madrid, SpainSearch for more papers by this author First published: 10 April 2008 https://doi.org/10.1111/j.1478-3231.2007.01665.xCitations: 72Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Esteve M, Saro C, González-Huix F, et al. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 2004; 54: 1363–5. 2 Persico E, De Renzo A, La Mura V, et al. Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients. Gut 2007; 56: 1470–1. 3 Madonia S, Orlando A, Scimeca D, Olivo M, Rossi F, Cottone M. Occult hepatitis B and infliximab-induced HBV reactivation. Inflammatory Bowel Disease 2007; 13: 509. 4 Zoulim F. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol 2005; 42: 302–8. 5 Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001; 34: 194–203. 6 Ganem D, Prince AM. Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med 2004; 350: 1118–29. 7 Marinos G, Naoumov NV, Rossol S, et al. Tumor necrosis factor in patients with chronic hepatitis B infection. Gastroenterology 1995; 108: 1453–63. Citing Literature Volume28, Issue5May 2008Pages 718-720 ReferencesRelatedInformation
Referência(s)